强生CEO：无意进军肥胖药市场
2026-06-17 14:28:54
强生首席执行官Joaquin Duato表示，公司无计划进入快速增长的肥胖市场，将把重点放在癌症等疾病领域。据 Bloomberg 报道，他在接受凯雷集团联合创始人David Rubenstein采访时作出上述表态。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Trace Finance完成3.2亿元A轮融资Next article：
两人认罪：涉骗取100万美元房款
